Leaps by Bayer and Khloris join forces to develop induced pluripotent stem cells (iPSCs) as breakthrough anti-cancer vaccines

Seed investment of Leaps by Bayer paves an exclusive leadership position for next generation oncology business / Research study from Stanford University suggests that vaccination with iPSCs may cure and prevent the development of many types of cancer ...

Thought leaders emphasize cattle health and well-being for the sustainable development of the beef industry

More than 220 cattle professionals engage over key topics of parasite control, bovine respiratory disease, reproduction, digital innovation and well-being at the 2nd Bayer International Beef Symposium ...

CVBD World Forum discuss a changing world in vector-borne Diseases

The 14th CVBD™ (Companion Vector-Borne Diseases) World Forum welcomed parasitologists, veterinary clinicians and epidemiology experts ...

Bayer statement on jury’s decision in phase two of California glyphosate trial

Bayer to showcase latest oncology research at AACR 2019 underscoring its commitment to advancing the future of cancer care

Data presentation from ongoing Phase I study with BAY 2731954 (formerly LOXO-195), an oral and selective investigational next-generation TRK inhibitor ...

Bayer receives positive opinion from European Medicines Agency for Baycox® Iron injection for piglets

Bayer’s novel, patented toltrazuril plus gleptoferron injectable combination is a step closer to European authorization ...

Bayer reaches settlement to resolve Xarelto™ litigation

Bayer is taking collaboration with health care start-ups to the next level

G4A Partnerships strengthens focus on co-creation and scaling by committed partnerships / Collaboration programs are being combined and longer-term oriented ...

Bayer statement on jury’s decision in phase one of California glyphosate trial

Bayer Animal Health launches Seresto™ collar in China

The flea and tick collar Seresto™ is one of the fastest growing brands in the Animal Health industry. ...